On December 5, 2025, four national food and beverage trade associations (the American Beverage Association, the Consumer Brands Association, the National Confectioners Association, and FMI the Food Industry Association) filed…
more
/ Administrative Law, Constitutional Law, Health
On November 18, 2025, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a precedential decision in Duke University, Allergan Sales, LLC v. Sandoz Inc., holding claim 30 of U.S. Patent No. 9,579,270…
more
/ Intellectual Property, Science, Computers, & Technology
On 4 December 2025, the Council of the European Union and the European Parliament reached a provisional agreement on a comprehensive framework for New Genomic Techniques (NGTs). The deal modernises EU agrifood rules and…
more
/ Agriculture, Environmental Law, Intellectual Property
This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how artificial intelligence is revolutionizing research, innovation, and patient care in the life sciences. Stay…
more
/ Intellectual Property, Science, Computers, & Technology
The BIOSECURE Act has returned in the 2025 legislative session in a new form as part of the Senate-passed version of the National Defense Authorization Act. The BIOSECURE Act (the “BIOSECURE Act” or the “Act”) was first…
more
/ Health, Science, Computers, & Technology, Government Contracting
On September 23, 2025, the FDA published three new draft guidances that give insight into a regulatory framework for cell and gene therapies (CGTs) that is now coming into focus. By releasing these guidances together, FDA is…
more
/ Administrative Law, Health, Science, Computers, & Technology
2024 was a challenging year for M&A activity in the medical technology (“MedTech”) industry. Although some sectors experienced a rebound in deal volume, MedTech dealmakers were disproportionately affected by a difficult…
more
/ Health, Mergers & Acquisitions, Science, Computers, & Technology
On June 30, 2025, the Federal Circuit issued a precedential decision in Eye Therapies, LLC v. Slayback Pharma, LLC, reversing the Patent Trial and Appeal Board’s (PTAB’s) claim construction of the phrase “consisting essentially…
more
/ Intellectual Property
Effective July 8, 2025, the U.S. Patent and Trademark Office (USPTO) expanded the availability of prioritized examination, increasing the limit on the number of requests from 15,000 to 20,000 in a fiscal year. The 20,000 limit…
more
/ Administrative Law, Intellectual Property
Cell and gene therapies represent a transformative frontier in modern medicine, offering potential cures for previously untreatable conditions. However, securing intellectual property (IP) protection for these innovations…
more
/ Health, Intellectual Property, Science, Computers, & Technology
The Federal Circuit issued a precedential opinion in In re: Xencor, Inc.concerning written support for Jepson claims. The decision affirms the decision of the Appeals Review Panel (ARP) of the USPTO, which held that the pending…
more
/ Intellectual Property
On June 10, 2025, the United States Patent and Trademark Office (USPTO) announced that, after nearly 20 years, it will be discontinuing its Accelerated Examination Program for utility applications on July 10, 2025.
The USPTO’s…
more
/ Administrative Law, Intellectual Property
Artificial intelligence (AI) has quickly become a springboard for breakthroughs in personalized medicine, enhanced medical imaging, and predictive modeling for drug development. And given the role it played in two recent Nobel…
more
/ Health, Intellectual Property, Science, Computers, & Technology
AI is transforming the life sciences industry by accelerating drug discovery and personalizing patient care. But as companies increasingly rely on AI to process genetic, biometric, and other types of health data, they must also…
more
/ Consumer Protection, Health, Privacy, Science, Computers, & Technology
This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how artificial intelligence is revolutionizing research, innovation, and patient care in the life sciences. Stay…
more
/ Health, Intellectual Property, Science, Computers, & Technology
